Anti-CD40 ChiLob7/4 (BioNTech) |
|
Phase 2 Clinical |
Biontech Se |
Head and Neck Neoplasms; Pancreatic Neoplasms |
Details
|
BSI-038 |
BSI-038 |
Phase 1 Clinical |
Boaoxin Biotechnology(Nanjing) Co Ltd |
Solid tumours |
Details
|
KPL-404 |
KPL-404 |
|
Kiniksa Pharmaceuticals Ltd |
|
Details
|
MIL-97 |
MIL-97 |
Phase 1 Clinical |
Beijing Mabworks Biotech Co Ltd |
Solid tumours |
Details
|
TQB-2916 |
TQB2916; TQB-2916 |
Phase 1 Clinical |
Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group |
Neoplasms |
Details
|
Ravagalimab |
ABBV-323; PR-1629977 |
|
Abbvie Inc |
|
Details
|
MEDI-5083 |
MEDI-5083 |
|
Astrazeneca Plc, Medimmune |
|
Details
|
ABBV-428 |
ABBV-428; ABBV428 |
|
Abbvie Inc |
|
Details
|
NJA-730 |
NJA-730; NJA-730a; NJA-730b |
Phase 1 Clinical |
Napajen Pharma |
Autoimmune Diseases |
Details
|
HPV CD40 HVac |
HPV CD40 HVac |
Clinical |
LinKinVax |
Papillomavirus Infections |
Details
|
SHR-1704 |
SHR-1704 |
Phase 1 Clinical |
Jiangsu Hengrui Medicine Co Ltd |
Neoplasms |
Details
|
IMB-071703 |
IMB071703; IMB-071703 |
Phase 1 Clinical |
Beijng Immunoah Pharma Tech Co Ltd |
Solid tumours |
Details
|
BI-655064 |
BI-655064 |
Phase 2 Clinical |
C.H. Boehringer Sohn Ag & Co. Kg |
Purpura, Thrombocytopenic, Idiopathic; Arthritis, Rheumatoid; Lupus Nephritis |
Details
|
2141-V11 |
2141-V11 |
Phase 1 Clinical |
Darell Bigner |
Ganglioglioma; Urinary Bladder Neoplasms; Glioma |
Details
|
Bleselumab |
4D-11; ASKP-1240 |
Phase 2 Clinical |
Kyowa Hakko Kogyo Co Ltd |
Rejection of renal transplantation; Rejection of organ transplantation; Psoriasis; Glomerulosclerosis, Focal Segmental |
Details
|
Autologous IL2 and CD40 ligand-expressing tumor cells (Baylor College of Medicine) |
|
Phase 1 Clinical |
Baylor College Of Medicine |
Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
CD40.HIVRI.Env Vaccine |
|
Phase 1 Clinical |
Anrs |
HIV Infections |
Details
|
SL-172154 |
SL-172154 |
Phase 1 Clinical |
Shattuck Labs Inc |
Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Myelodysplastic Syndromes; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Squamous Cell; Fallopian Tube Neoplasms |
Details
|
LVGN-7409 |
LVGN7409; LVGN-7409 |
Phase 1 Clinical |
Lyvgen Biopharma(HK)Ltd |
Ovarian Neoplasms; Head and Neck Neoplasms; Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Neoplasms; Papillomavirus Infections; Uveal melanoma; Sarcoma; Neoplasm Metastasis; Carcinoma, Hepatocellular |
Details
|
Mitazalimab |
ADC-1013; JNJ-7107; JNJ-64457107 |
Phase 2 Clinical |
Alligator Bioscience Ab |
Solid tumours; Neoplasms; Carcinoma, Pancreatic Ductal |
Details
|
Giloralimab |
ABBV-927 |
Phase 2 Clinical |
Abbvie Inc |
Head and Neck Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
RO-7300490 |
RO-7300490; RG-6189 |
Phase 1 Clinical |
F. Hoffmann-La Roche Ltd |
Solid tumours; Neoplasms |
Details
|
Cifurtilimab |
SEA-CD40 |
Phase 2 Clinical |
Seattle Genetics Inc |
Lymphoma, B-Cell; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Lymphoma, Large B-Cell, Diffuse; Hodgkin Disease; Neoplasms, Squamous Cell; Pancreatic Neoplasms; Lymphoma, Follicular; Carcinoma, Squamous Cell; Lymphoma, Non-Hodgkin; Lymphoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis |
Details
|
Iscalimab |
CFZ-533; NVP-CFZ533; OM11-62-MF |
Phase 2 Clinical |
Novartis Pharma Ag |
Diabetes Mellitus, Type 1; Rejection of renal transplantation; Myasthenia Gravis; Rejection of liver transplantation; Arthritis, Rheumatoid; Sjogren's Syndrome; Lupus Nephritis; Lupus Erythematosus, Systemic; Graves Disease; Sjogren-Larsson Syndrome; Hidradenitis Suppurativa |
Details
|
Sotigalimab |
APX-005M; EPI-0050; APX-005 |
Phase 2 Clinical |
Epitomics Inc |
Glioblastoma; Carcinoma, Non-Small-Cell Lung; Melanoma; Glioma; Lung Neoplasms; Astrocytoma; Sarcoma; Microsatellite Instability; Central Nervous System Neoplasms; Head and Neck Neoplasms; Pancreatic Neoplasms; Neoplasms; Carcinoma, Transitional Cell; Carcinoma, Renal Cell; Stomach Neoplasms; Esophageal Neoplasms; Medulloblastoma; Ependymoma |
Details
|
Inezetamab |
AMG-994 |
Phase 1 Clinical |
Amgen Inc |
Solid tumours; Neoplasms |
Details
|
Tecaginlimab |
BNT-312; GEN-1042 |
Phase 2 Clinical |
Genmab A/S |
Solid tumours; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Peripheral Nervous System Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung; Melanoma |
Details
|
CDX-1140 |
CDX-1140 |
Phase 2 Clinical |
Celldex Therapeutics |
Uveal melanoma; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung; Melanoma; Waldenstrom Macroglobulinemia; Fallopian Tube Neoplasms; Lymphoma, Non-Hodgkin; Lung Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Lymphoma, Follicular; Cholangiocarcinoma; Lymphoma, Mantle-Cell; Breast Neoplasms; Urinary Bladder Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Pancreatic Neoplasms; Esophageal Neoplasms; Carcinoma, Renal Cell; Stomach Neoplasms; Carcinoma; Lymphoma, B-Cell, Marginal Zone; Head and Neck Neoplasms; Ovarian Neoplasms; Liver Neoplasms; Lymphoma, B-Cell |
Details
|
YH-003 |
YH-003; YH003 |
Phase 2 Clinical |
Eucure Pharmaceutical Technology (Beijing) Co Ltd |
Solid tumours; Pancreatic Neoplasms; Neoplasms; Carcinoma, Pancreatic Ductal; Melanoma |
Details
|
CD40L-GVAX |
GM.CD40L; CD40L-GVAX; GM-CSF/CD40L; hCD40L/hGM-CSF |
Phase 2 Clinical |
University Of South Florida |
Leukemia; Adenocarcinoma of Lung; Myelodysplastic Syndromes; Lung Neoplasms; Melanoma; Adenocarcinoma |
Details
|